Gresham, ORNCT07506876Now EnrollingIRB Ready

Breast Cancer - Infiltrating Ductal Carcinoma Clinical Trial in Gresham, OR

Access cutting-edge breast cancer - infiltrating ductal carcinoma treatment through this clinical trial at a research site in Gresham. Study-provided care at no cost to qualified participants.

Sponsored by Legacy Health System

Quick Self-Assessment

See if you qualify for this Gresham location

Preparing your pre-screening questions…

Expert Care in Gresham

Access breast cancer - infiltrating ductal carcinoma specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related breast cancer - infiltrating ductal carcinoma treatment provided free

Apply for This Gresham Location

Check if you qualify for this breast cancer - infiltrating ductal carcinoma clinical trial in Gresham, OR

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to Gresham

    Convenient for OR residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit Gresham site if eligible
  4. 4Begin participation

About This Breast Cancer - Infiltrating Ductal Carcinoma Study in Gresham

The usual approach to care for hormone receptor positive, HER2 positive breast cancer is chemotherapy and HER2 targeted therapy followed by endocrine therapy and surgery. The purpose of this Research Study is to see if taking endocrine therapy with the chemotherapy and HER2 directed therapy increases patients response to therapy at the time of surgery

Sponsor: Legacy Health System

Who Can Participate

Inclusion Criteria

Adults over 18 years of age with newly diagnosed, previously untreated, HR+, HER2+ breast cancer (positive per local guidelines)
Endocrine therapy for the current breast cancer may be started within 28 days prior to trial enrollment and must be initiated prior to C2 of chemotherapy/HER2 directed therapy
Choice of endocrine therapy will be determined by the treating and/or enrolling physician
Anatomic Stage IIA - IIIC breast cancer planning a minimum of 4 cycles of TCHP
Patients must be Luminal A, Luminal B or HER2 enriched subtype on MammaPrint/BluePrint performed on initial biopsy

Exclusion Criteria

Children under 18 years of age, pregnant women, prisoners, and decisionally impaired adults.
Patients with non-breast cancer within prior 2 years
Patients with breast cancer within prior 5 years
Patients with recurrent breast cancer
Patients with stage IV breast cancer

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in Gresham?

Yes, this clinical trial (NCT07506876) has an active research site in Gresham, OR that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

Breast Cancer - Infiltrating Ductal Carcinoma Treatment Options in Gresham, OR

If you're searching for breast cancer - infiltrating ductal carcinoma treatment options in Gresham, OR, this clinical trial (NCT07506876) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our Gresham research site is actively enrolling participants for this clinical trial. You'll receive care from experienced breast cancer - infiltrating ductal carcinoma specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all breast cancer - infiltrating ductal carcinoma clinical trials near you to find additional studies recruiting in your area.

More Breast Cancer Trials in Gresham, OR

See all breast cancer clinical trials recruiting in Gresham — not just this study.

Browse Breast Cancer Trials in Gresham

Ready to Join in Gresham?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · Gresham, OR